Paul Sargos

Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial

Paul Sargos, Sylvie Chabaud, I. Latorzeff et al. · The Lancet Oncology · 2020 · 322 citations · Full text

Medicine, Oncology, Urology +17

Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial

C. Carrié, Nicolas Magné, Patricia Burban-Provost et al. · The Lancet Oncology · 2019 · 250 citations · Full text

Medicine, Oncology, Urology +16

First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas

Sylvie Bonvalot, C. Le Péchoux, Thierry de Baère et al. · Clinical Cancer Research · 2016 · 234 citations

Medicine, Oncology, Radiation Oncology +17

Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study

M. Savina, Axel Le Cesne, Jean‐Yves Blay et al. · BMC Medicine · 2017 · 212 citations · Full text

Medicine, Clinical Sciences, Oncology +13

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†

J. Alfred Witjes, Marek Babjuk, Joaquim Bellmunt et al. · European Urology · 2019 · 192 citations · Full text

Medicine, Oncology, Urology +16